Evidence mapPaperPMID 41639740Full record

ReviewBiomarker research2026

Mitochondrial DNA mutations and intercellular mitochondrial transfer in cancer: mechanisms, biological effects, and clinical potential.

Yijia Chen, Hanzhe Shi, Mingming Xiao, Haoqi Pan, Xiaoning Yu, Yicheng Zhu, Jing Yang, Wei Wang, Jin Xu, Xianjun Yu and 1 more

Abstract readReview
In one paragraph

Review in Biomarker research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yijia Chen *Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, No. 270 Dong'An Road, Xuhui District, Shanghai, 200032, China.
Hanzhe Shi *Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, No. 270 Dong'An Road, Xuhui District, Shanghai, 200032, China.
Mingming Xiao *Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, No. 270 Dong'An Road, Xuhui District, Shanghai, 200032, China.
Haoqi PanDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, No. 270 Dong'An Road, Xuhui District, Shanghai, 200032, China.
Xiaoning YuDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, No. 270 Dong'An Road, Xuhui District, Shanghai, 200032, China.
Yicheng ZhuDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, No. 270 Dong'An Road, Xuhui District, Shanghai, 200032, China.
Jing YangDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, No. 270 Dong'An Road, Xuhui District, Shanghai, 200032, China.
Wei WangDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, No. 270 Dong'An Road, Xuhui District, Shanghai, 200032, China.
Jin XuDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, No. 270 Dong'An Road, Xuhui District, Shanghai, 200032, China.
Xianjun YuDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, No. 270 Dong'An Road, Xuhui District, Shanghai, 200032, China. yuxianjun@fudanpci.org.
Si ShiDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, No. 270 Dong'An Road, Xuhui District, Shanghai, 200032, China. shisi@fudanpci.org.ORCID http://orcid.org/0000-0002-6652-0629

Funding

National Natural Science Foundation of China 82503859National Natural Science Foundation of China 92374102National Natural Science Foundation of China U21A20374Noncommunicable Chronic Diseases-National Science and Technology Major Project 2024ZD0525500/2024ZD0525501/2024ZD0525505Science and Technology Commission of Shanghai Municipality 23ZR1479300Science and Technology Commission of Shanghai Municipality 25ZR1402085Science and Technology Commission of Shanghai Municipality YDZX20243100002003
6 · The paper itself

Abstract

Mitochondrial DNA (mtDNA) mutations are frequently detected in tumor cells and represent a distinctive aspect of cancer genomics. Common types of mtDNA alterations include single nucleotide variants, insertions and deletions, and copy number changes. These mutations often result in a range of biological effects, encompassing both in situ and ectopic mechanisms. In situ, mutant mtDNA may lead to respiratory chain dysfunction, impairing oxidative phosphorylation and shifting energy production toward glycolysis and other metabolic pathways. This metabolic reprogramming, along with altered glutamine and lipid metabolism, is frequently accompanied by reactive oxygen species accumulation, which can activate pro-tumorigenic signaling cascades and contribute to genomic instability. These changes promote cancer cell proliferation, enhance invasive and metastatic potential, and facilitate immune evasion. Moreover, through mitochondrial transfer mechanisms such as tunneling nanotubes, extracellular vesicles, cell fusion, or gap junction channels, mutant mtDNA can be transmitted to other cells, serving as an important mode of intercellular communication within tumors. This process promotes tumor progression and metastasis, regulates apoptotic pathways, facilitates immune evasion, and enhances therapeutic resistance, allowing mutant mtDNA to exert ectopic effects. Clinically, mtDNA mutations hold substantial potential in oncology, with applications spanning tumor diagnosis, disease monitoring, therapeutic resistance prediction, and prognosis assessment. Analysis of tumor tissue or circulating cell-free mtDNA provides a promising non-invasive approach for these purposes. In addition, the involvement of mtDNA mutations in regulating tumor metabolism and mediating intercellular communication underscores their value as potential therapeutic targets, making them a prominent focus of current cancer research.

Indexed as

Cancer therapyImmunotherapyMitochondrial DNA mutationMitochondrial transferTumor microenvironment

Identifiers

PMID41639740
PMCPMC12922255

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.